Industrial Enzyme Thermostability Engineering for High-Temperature Bioprocessing

All case studies

Industrial Biotech

Industrial Enzyme Thermostability Engineering for High-Temperature Bioprocessing

Industrial biotech needed a cellulase variant stable above 75°C for a next-generation biofuel pretreatment line.

Company

Industrial biotech division (Fortune 500 subsidiary, 12-person R&D team)

Timeline

April to May 2025

Engagement

Protein Design and Developability Pipeline

Protein Engineering

3 wks: Computational delivery
+22°C: ΔTm on lead variant
78%: Activity retained at 75°C
8/10: Expressing variants (E. coli)

The Challenge

An industrial biotech team was optimizing a fungal cellulase cocktail for lignocellulosic biofuel production. The wild-type endoglucanase lost 90% activity above 65°C, limiting pretreatment throughput on their pilot line. Directed evolution over 14 months had produced variants with +8°C Tm improvement but plateaued. They needed computationally designed variants targeting +15 to 20°C Tm gain while maintaining catalytic activity at pH 4.8, before a $12M pilot scale-up decision.

Business Constraints

Budget: $295K (protein engineering line item)
Timeline: Ranked enzyme variants in 3 weeks
Must express in E. coli (no fungal expression system change)
Activity at 75°C must exceed 70% of wild-type activity at optimal temperature

ProteinForge Approach

Week 1: Stability Mapping and Mutation Library Design

Input

Wild-type endoglucanase structure (AlphaFold model, validated against homolog PDB: 4AAJ)
Directed evolution trajectory (47 variants with Tm and activity data)
Active site conservation analysis and catalytic triad mapping

Methods

ESM-2 mutational scanning across 380 surface and core positions
Rosetta ddG stability prediction for 840,000 single and double mutants
Active site exclusion zone (8Å radius) to protect catalytic residues

Output

Top 6,200 variants ranked by predicted ΔTm
Activity retention probability scores for catalytic site-proximal mutations

Week 2: Combinatorial Design and Activity Filtering

Epistatic combination of top 40 stabilizing mutations generated 12,000 multi-point variants. Molecular dynamics at 400K for 100ns on top 200 candidates validated structural integrity. pH-dependent charge analysis filtered variants with pI shifts that would affect activity at pH 4.8. Solubility and E. coli expression probability scoring reduced pool to 65 candidates with predicted Tm gains of +12 to +26°C.

Week 3: Ranking and Expression Priority List

Output

Top 35 enzyme variants ranked by predicted Tm, activity retention, and E. coli expression score
Expression priority list for top 10 (E. coli codon-optimized sequences)
Recommended validation protocol: thermal shift assay (DSF), activity at 25/55/65/75°C, pilot reactor test
Mutation map showing additive vs. epistatic stabilizing combinations

Final Ranked Enzyme Variants

Top candidates shown; full list of 35 delivered with expression-ready sequences.

Top thermostabilized cellulase variants by predicted Tm and activity retention
Rank	Mutations	Predicted ΔTm (°C)	Activity Score	Expression	Status
1	S142P + A198V + L241I	+22	0.91	0.88	Priority A
2	S142P + T89K + L241I	+20	0.89	0.85	Priority A
3	A198V + D156N + L241I + V203A	+24	0.84	0.82	Priority A
4–5	Mixed (3–4 mutations)	+18 to +21	0.82–0.88	0.78–0.86	Priority B
6–10	Mixed (2–5 mutations)	+14 to +19	0.78–0.85	0.72–0.84	Priority B
11–35	Mixed	+10 to +16	0.70–0.82	0.65–0.80	Backup

Results and impact

Speed, validation, and business outcomes

Speed vs. Prior Directed Evolution Campaign

Metric	Directed Evolution	ProteinForge	Improvement
Timeline	14 months	3 weeks	18× faster
Cost	$680K (incl. screening)	$295K	57% savings
Variants Evaluated	47 (physical)	840K+ (in silico)	18,000× larger search
Best ΔTm Achieved	+8°C	+22°C (validated)	2.75× greater improvement

Wet-Lab Validation Outcomes (6 weeks post-delivery)

Expression, thermal stability, and activity results on top 10 expressed variants.

Variant	Predicted ΔTm	Observed Tm (°C)	Activity at 75°C	Expressing?	Notes
Rank 1	+22°C	87	78%	Yes	Best overall; pilot reactor validated
Rank 2	+20°C	85	81%	Yes	Highest activity retention at 75°C
Rank 3	+24°C	89	72%	Yes	Highest Tm; slight activity trade-off
Rank 4	+19°C	84	76%	Yes	Good balance of stability and activity
Rank 5	+18°C	83	74%	Yes	Acceptable for backup series
Rank 6–8	+14 to +17°C	80–82	70–75%	Yes (3/3)	3 additional validated variants
Rank 9–10	+12 to +15°C	Mixed	Low	1/2	Activity loss at active site proximity

8/10: E. coli expression success (top 10)
+22°C: Best validated ΔTm improvement
78%: Activity retained at 75°C (Rank 1)
6 wks: Timeline to pilot-validated variant

Immediate Wins

Pilot scale-up approved: Rank 1 variant validated on 500L reactor; $12M scale-up decision de-risked
Process throughput increased 35% at elevated pretreatment temperature
Patent filing: 3 novel stabilizing mutation combinations with no prior art overlap

Strategic Advantages

Epistatic mutation combinations identified computationally that directed evolution missed over 14 months
Active site exclusion zone preserved catalytic activity while allowing surface stabilization
E. coli expression pre-filter prevented 6 variants that would have failed production constraints

Follow-on engagement
Q3 2025: cocktail optimization combining Rank 1 endoglucanase with complementary cellobiohydrolase via ProteinForge. Estimated cost: $240K. Target: full cellulase cocktail stable above 75°C.

Model validation

Lessons and recommendations

What Worked

ESM-2 + Rosetta ddG ensemble outperformed either method alone for ΔTm prediction (R² = 0.76 vs. 0.58/0.64)
400K MD simulations caught 8 variants with predicted stability gains but unfolding trajectories
Prior directed evolution data as training signal improved activity retention scoring accuracy

Challenges and Mitigations

Rank 3 achieved highest Tm (+24°C) but 72% activity at 75°C vs. 78% for Rank 1. Root cause: core mutation near substrate binding groove.

Mitigation: Tightened active site exclusion to 10Å for multi-point variants; added activity retention as co-primary rank key.

Two variants with strong in vitro stability showed reduced performance in pilot reactor due to shear sensitivity.

Mitigation: Added surface charge and glycosylation site analysis to developability filter for industrial deployment context.

When to use ProteinForge for enzyme engineering

Directed evolution campaigns that have plateaued on stability or activity
Industrial enzymes requiring simultaneous thermostability and activity optimization
Expression system constraints (E. coli, yeast) that limit wet-lab screening throughput
Scale-up decisions requiring validated variants before capital commitment

ROI: approximately 8:1 (pilot scale-up value + avoided repeat evolution + 18× faster timeline).

Next steps: optimize full enzyme cocktail for industrial bioprocessing; iterate with pilot reactor feedback for closed-loop improvement.

About This Engagement

Client profile: Fortune 500 industrial biotech subsidiary, 12-person R&D team
Project duration: 3 weeks (computational delivery) + 6 weeks (validation)
Total cost: $295K
Date: April to May 2025

This case study is anonymized at client request. Enzyme sequences and institutional affiliations have been redacted. Full protocols available under NDA.

Run a similar program with ProteinForge.

Tell us about your target. We will scope a 2 to 4 week pilot.

Schedule a Consultation [email protected]